All You Need to Know About ‘Arcturus’ COVID-19 Variant
Table of Contents
A visitor wearing a face mask takes a photo of a model of a coronavirus and boxes for COVID-19 vaccines at a display by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services (CIFTIS) in Beijing, Saturday, Sept. 5, 2020. With the COVID-19 pandemic largely under control, China’s capital on Saturday kicked off one of the first large-scale public events since the start of the coronavirus outbreak, as tens of thousands of attendees were expected to visit displays from nearly 2,000 Chinese and foreign companies showcasing their products and services.InternationalIndiaAfricaThe Covid subvariant, one of hundreds to spawn from the Omicron variant of the SARS-COV-2 virus, doesn’t seem to be more lethal than the others, but health officials are watching as it slowly spreads around the world. More infectious virus variants tend to displace less infectious competitors and become the dominant cause of infection.The World Health Organization (WHO) has designated the new coronavirus subvariant XBB.1.16 as a “variant under monitoring, but so far isn’t sounding the alarms. Because of its mouthful of a name, the subvariant is better known as “Arcturus,” following a semi-official subvariant naming scheme derived from mythological characters that the WHO has not yet adopted.Outside of COVID-19 virology, Arcturus is a red giant star found in the constellation Bootes, and the fourth-brightest star in the night sky as seen from Earth. Its name in Ancient Greek means “Guardian of the Bear.” The subvariant was first detected in January.
More Infectious, No More Deadly
Although it has emerged as a distinct subvariant of Omicron, a WHO-named COVID-19 variant that was first detected in late 2021 and has been the dominant variant globally for nearly 16 months, Arcturus doesn’t seem to be too different from its parent virus.“It’s been in circulation for a few months,” Maria Van Kerkhove, the WHO’s technical lead for Covid, said at a March 29 press conference.“We haven’t seen a change in severity in individuals or in populations, but that’s why we have these systems in place. It has one additional mutation in the spike protein, which, in lab studies, shows increased infectivity as well as potential increased pathogenicity,” she added.AmericasBiden Signs Bill Ending US COVID-19 National Emergency – White House11 April, 01:14 GMTIn other words, it’s a bit more infectious than Omicron, but not by much, and the symptoms don’t seem to be any worse than Omicron. Work by Japanese doctors suggests it might be 1.2 times more infectious than Omicron. There hasn’t been a detected increase in deaths related to Arcturus, either.
In addition to the classic flu-like symptoms of COVID-19, such as coughing, fever, chills, and loss of sense of taste, doctors have identified some new symptoms unique to the Arcturus subvariant.According to Vipin Vashishtha, a pediatrician and former head of the Indian Academy of Pediatrics Committee on Immunization, the large outbreak in India has shown doctors that Arcturus commonly brings with it “itchy” conjunctivitis or pinkeye not seen in other COVID-19 cases.
Where Has Arcturus Been Found?
Arcturus is blamed for a large outbreak currently underway in India, where officials have tracked at least 50,000 new cases per day in recent weeks. However, the subvariant has been detected in 22 countries, with small numbers of cases found in the United Kingdom and United States recently.The variant tracker at the US Centers for Disease Control and Prevention (CDC) shows small numbers of cases being detected in over a dozen US states, but none increasing very rapidly. In the UK, just 50 cases have been spotted so far.Americas‘Unprecedented Greed’: Sanders Slams Moderna After Company Confirms $130 Price for Covid Jab23 March, 20:06 GMT“We’ve seen this in the past,” Paul Hunter, a professor of medicine at the University of East Anglia, told US media. “You look at the virus and it’s got mutations that should make it more virulent, but then in reality you don’t see that.”“There’s no evidence that this is any more severe – and probably it’s somewhat less severe than previous strains – but it’s too early to be certain. And that’s almost certainly because of immunity,” Hunter explained. “It will probably become the dominant variant for a while in the U.S. and Europe and most countries around the world, but I don’t see it driving up severe infections more than we’ve seen in recent waves.”He added that there is evidence that past COVID-19 infection, as well as multivalent SARS-CoV-2 vaccination, are both having an effect on immunity, although the variant could still circulate for years to come.